Artivion | CRY - Stock


Artivion reported $97.99M in Stock for its fiscal quarter ending in March of 2026.





Stock Change Date
Abbott USD 6.99B 501M Mar/2026
Accuray USD 150.96M 4.54M Dec/2025
AngioDynamics USD 65.57M 3.56M Sep/2025
Artivion USD 97.99M 5.57M Mar/2026
AtriCure USD 81.14M 2.65M Mar/2026
Baxter International USD 2.32B 84M Mar/2026
Becton, Dickinson and Co. USD 3.36B 728M Mar/2026
Boston Scientific USD 3.12B 174M Mar/2026
Edwards Lifesciences USD 1.12B 7.2M Mar/2026
Inogen USD 25.08M 762K Sep/2025
Integra LifeSciences USD 495.04M 2.3M Mar/2026
J&J USD 14.58B 392M Mar/2026
Mesa Laboratories USD 26.56M 1.18M Dec/2025
Orthofix International USD 177.82M 5.5M Mar/2026
Pfizer USD 10.67B 13M Mar/2026
ResMed USD 911.88M 10.17M Mar/2026
Stryker USD 5.42B 109M Mar/2026
Surmodics USD 15.17M 230K Sep/2024
Tandem Diabetes Care USD 126.4M 2.37M Mar/2026
Teleflex USD 380.86M 23.53M Mar/2026
Terumo JPY 311.91B 10.92B Sep/2025
Trinity Biotech USD 19.16M 210K Sep/2025